IKK/Nuclear Factor-kappaB and Oncogenesis: Roles in tumor-initiating cells and in the tumor microenvironment

Advances in Cancer Research

Volumn 121, Issue , 2014, Pages 125-145

  Bradford, Jennifer W ^a   Baldwin, Albert S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer associated fibroblast; Cytokine; Nuclear factor kappaB; Regulatory T lymphocyte; Stroma; Tumor associated macrophage; Tumor initiating cell

Indexed keywords

CHEMOKINE RECEPTOR CCR2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; I KAPPA B KINASE;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER STEM CELL; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL MIGRATION; COLON CANCER; EPITHELIUM CELL; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; KUPFFER CELL; LEWIS CARCINOMA; LIVER CELL; LUNG TUMOR; MACROPHAGE; MESENCHYMAL STROMA CELL; METASTASIS ASSOCIATED MACROPHAGE; NONHUMAN; PANCREAS CANCER; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTATE CANCER; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR ASSOCIATED T LYMPHOCYTE; TUMOR GROWTH; TUMOR INITIATING CELL; TUMOR MICROENVIRONMENT; TUMOR VOLUME; WNT SIGNALING PATHWAY; ANIMAL; GENETICS; METABOLISM; NEOPLASMS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARCINOGENESIS; HUMANS; I-KAPPA B KINASE; NEOPLASMS; NEOPLASTIC STEM CELLS; NF-KAPPA B; TUMOR MICROENVIRONMENT;

EID: 84901495560     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800249-0.00003-2     Document Type: Chapter

References (89)

1. Annunziata C.M., Davis R.E., Demchenko Y., Bellamy W., Gabrea A., Zhan F., et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 2007, 12:115-130.
2. Anton K., Glod J. Targeting the tumor stroma in cancer therapy. Current Pharmaceutical Biotechnology 2009, 10:185-191.
3. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. The Journal of Clinical Investigation 2001, 107:241-246.
4. Baldwin A.S. Regulation of cell death and autophagy by IKK and NF-kappaB: Critical mechanisms in immune function and cancer. Immunological Reviews 2012, 246:327-345.
5. Bang D., Wilson W., Ryan M., Yeh J.J., Baldwin A.S. GSK-3alpha promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-kappaB. Cancer Discovery 2013, 3:690-703.
6. Basseres D.S., Baldwin A.S. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 2006, 25:6817-6830.
7. Basseres D.S., Ebbs A., Levantini E., Baldwin A.S. Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis. Cancer Research 2010, 70:3537-3546.
8. Beroukhim R., Mermel C.H., Porter D., Wei G., Raychaudhuri S., Donovan J., et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463:899-905.
9. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
10. Biswas S.K., Gangi L., Paul S., Schioppa T., Saccani A., Sironi M., et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood 2006, 107:2112-2122.
11. Biswas S.K., Lewis C.E. NF-kappaB as a central regulator of macrophage function in tumors. Journal of Leukocyte Biology 2010, 88:877-884.
12. Boehm J.S., Zhao J.J., Yao J., Kim S.Y., Firestein R., Dunn I.F., et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007, 129:1065-1079.
13. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends in Immunology 2004, 25:280-288.
14. Cao Y., Luo J.L., Karin M. IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:15852-15857.
15. Charafe-Jauffret E., Ginestier C., Birnbaum D. Breast cancer stem cells: Tools and models to rely on. BMC Cancer 2009, 9:202.
16. Chaudhri V.K., Salzler G.G., Dick S.A., Buckman M.S., Sordella R., Karoly E.D., et al. Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumor. Molecular Cancer Research 2013, 11:579-592.
17. Connelly L., Barham W., Onishko H.M., Chen L., Sherrill T.P., Zabuawala T., et al. NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis model. Breast Cancer Research 2011, 13:R83.
18. Dan H.C., Adli M., Baldwin A.S. Regulation of mammalian target of rapamycin activity in PTEN-inactive prostate cancer cells by I kappa B kinase alpha. Cancer Research 2007, 67:6263-6269.
19. Dan H.C., Cooper M.J., Cogswell P.C., Duncan J.A., Ting J.P., Baldwin A.S. Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes & Development 2008, 22:1490-1500.
20. D'Angelo R.C., Wicha M.S. Stem cells in normal development and cancer. Progress in Molecular Biology and Translational Science 2010, 95:113-158.
21. DiDonato J.A., Mercurio F., Karin M. NF-kappaB and the link between inflammation and cancer. Immunological Reviews 2012, 246:379-400.
22. Duran A., Linares J.F., Galvez A.S., Wikenheiser K., Flores J.M., Diaz-Meco M.T., et al. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 2008, 13:343-354.
23. Erez N., Truitt M., Olson P., Arron S.T., Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010, 17:135-147.
24. Finco T.S., Westwick J.K., Norris J.L., Beg A.A., Der C.J., Baldwin A.S. Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. The Journal of Biological Chemistry 1997, 272:24113-24116.
25. Fridman W.H., Galon J., Pages F., Tartour E., Sautes-Fridman C., Kroemer G. Prognostic and predictive impact of intra- and peritumoral immune infiltrates. Cancer Research 2011, 71:5601-5605.
26. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annual Review of Immunology 1998, 16:225-260.
27. Ginestier C., Liu S., Diebel M.E., Korkaya H., Luo M., Brown M., et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. The Journal of Clinical Investigation 2010, 120:485-497.
28. Gordon S. Alternative activation of macrophages. Nature Reviews. Immunology 2003, 3:23-35.
29. Greten F.R., Eckmann L., Greten T.F., Park J.M., Li Z.W., Egan L.J., et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004, 118:285-296.
30. Hagemann T., Lawrence T., McNeish I., Charles K.A., Kulbe H., Thompson R.G., et al. "Re-educating" tumor-associated macrophages by targeting NF-kappaB. The Journal of Experimental Medicine 2008, 205:1261-1268.
31. Hagemann T., Wilson J., Burke F., Kulbe H., Li N.F., Pluddemann A., et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. Journal of Immunology 2006, 176:5023-5032.
32. Hagemann T., Wilson J., Kulbe H., Li N.F., Leinster D.A., Charles K., et al. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. Journal of Immunology 2005, 175:1197-1205.
33. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes & Development 2004, 18:2195-2224.
34. Hayden M.S., Ghosh S. NF-kappaB, the first quarter-century: Remarkable progress and outstanding questions. Genes & Development 2012, 26:203-234.
35. Hopewell E.L., Zhao W., Fulp W.J., Bronk C.C., Lopez A.S., Massengill M., et al. Lung tumor NF-kappaB signaling promotes T cell-mediated immune surveillance. The Journal of Clinical Investigation 2013, 123:2509-2522.
36. Hu M.C., Lee D.F., Xia W., Golfman L.S., Ou-Yang F., Yang J.Y., et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004, 117:225-237.
37. Iliopoulos D., Hirsch H.A., Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009, 139:693-706.
38. Iliopoulos D., Hirsch H.A., Wang G., Struhl K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:1397-1402.
39. Iliopoulos D., Jaeger S.A., Hirsch H.A., Bulyk M.L., Struhl K. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Molecular Cell 2010, 39:493-506.
40. Israel A. The IKK complex: An integrator of all signals that activate NF-kappaB?. Trends in Cell Biology 2000, 10:129-133.
41. Kaler P., Godasi B.N., Augenlicht L., Klampfer L. The NF-kappaB/AKT-dependent Induction of Wnt signaling in colon cancer cells by macrophages and IL-1beta. Cancer Microenvironment 2009, Epub ahead of print.
42. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annual Review of Immunology 2000, 18:621-663.
43. Kawauchi K., Araki K., Tobiume K., Tanaka N. p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nature Cell Biology 2008, 10:611-618.
44. Kawauchi K., Araki K., Tobiume K., Tanaka N. Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:3431-3436.
45. Keats J.J., Fonseca R., Chesi M., Schop R., Baker A., Chng W.J., et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 2007, 12:131-144.
46. Kendellen M.F., Bradford J.W., Lawrence C.L., Clark K.S., Baldwin A.S. Canonical and non-canonical NF-kappaB signaling promotes breast cancer tumor-initiating cells. Oncogene 2013, 33:1297-1305.
47. Korkaya H., Liu S., Wicha M.S. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. The Journal of Clinical Investigation 2011, 121:3804-3809.
48. Kurahara H., Shinchi H., Mataki Y., Maemura K., Noma H., Kubo F., et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. The Journal of Surgical Research 2011, 167:e211-e219.
49. Laoui D., Movahedi K., Van Overmeire E., Van den Bossche J., Schouppe E., Mommer C., et al. Tumor-associated macrophages in breast cancer: Distinct subsets, distinct functions. The International Journal of Developmental Biology 2011, 55:861-867.
50. Lee H., Herrmann A., Deng J.H., Kujawski M., Niu G., Li Z., et al. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 2009, 15:283-293.
51. Lenz G., Davis R.E., Ngo V.N., Lam L., George T.C., Wright G.W., et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 2008, 319:1676-1679.
52. Lewis C.E., Pollard J.W. Distinct role of macrophages in different tumor microenvironments. Cancer Research 2006, 66:605-612.
53. Ling J., Kang Y., Zhao R., Xia Q., Lee D.F., Chang Z., et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 2012, 21:105-120.
54. Liu M., Sakamaki T., Casimiro M.C., Willmarth N.E., Quong A.A., Ju X., et al. The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Research 2010, 70:10464-10473.
55. Luo J.L., Tan W., Ricono J.M., Korchynskyi O., Zhang M., Gonias S.L., et al. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 2007, 446:690-694.
56. Maeda S., Kamata H., Luo J.L., Leffert H., Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005, 121:977-990.
57. Mahmoud S.M., Lee A.H., Paish E.C., Macmillan R.D., Ellis I.O., Green A.R. Tumour-infiltrating macrophages and clinical outcome in breast cancer. Journal of Clinical Pathology 2012, 65:159-163.
58. Mantovani A. Cancer: Inflaming metastasis. Nature 2009, 457:36-37.
59. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
60. Martinez-Outschoorn U.E., Curry J.M., Ko Y.H., Lin Z., Tuluc M., Cognetti D., et al. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFkappaB target stromal MCT4. Cell Cycle 2013, 12:2580-2597.
61. Mayo M.W., Wang C.Y., Cogswell P.C., Rogers-Graham K.S., Lowe S.W., Der C.J., et al. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 1997, 278:1812-1815.
62. Merkhofer E.C., Cogswell P., Baldwin A.S. Her2 activates NF-kappaB and induces invasion through the canonical pathway involving IKKalpha. Oncogene 2010, 29:1238-1248.
63. Meylan E., Dooley A.L., Feldser D.M., Shen L., Turk E., Ouyang C., et al. Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 2009, 462:104-107.
64. Movahedi K., Laoui D., Gysemans C., Baeten M., Stange G., Van den Bossche J., et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Research 2010, 70:5728-5739.
65. Perkins N.D., Gilmore T.D. Good cop, bad cop: The different faces of NF-kappaB. Cell Death and Differentiation 2006, 13:759-772.
66. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466.
67. Pollard J.W. Macrophages define the invasive microenvironment in breast cancer. Journal of Leukocyte Biology 2008, 84:623-630.
68. Polyak K., Haviv I., Campbell I.G. Co-evolution of tumor cells and their microenvironment. Trends in Genetics 2009, 25:30-38.
69. Qian B.Z., Li J., Zhang H., Kitamura T., Zhang J., Campion L.R., et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011, 475:222-225.
70. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
71. Rahal R., Frick M., Romero R., Korn J.M., Kridel R., Chun Chan F., et al. Pharmacological and genomic profiling identifies NF-kappaB-targeted treatment strategies for mantle cell lymphoma. Nature Medicine 2014, 20:87-92.
72. Rajasekhar V.K., Studer L., Gerald W., Socci N.D., Scher H.I. Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling. Nature Communications 2011, 2:162.
73. Ren G., Zhao X., Wang Y., Zhang X., Chen X., Xu C., et al. CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFalpha. Cell Stem Cell 2012, 11:812-824.
74. Saccani A., Schioppa T., Porta C., Biswas S.K., Nebuloni M., Vago L., et al. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Research 2006, 66:11432-11440.
75. Schwitalla S., Fingerle A.A., Cammareri P., Nebelsiek T., Goktuna S.I., Ziegler P.K., et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 2013, 152:25-38.
76. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986, 46:705-716.
77. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 2001, 293:1495-1499.
78. Stein S.J., Baldwin A.S. Deletion of the NF-kappaB subunit p65/RelA in the hematopoietic compartment leads to defects in hematopoietic stem cell function. Blood 2013, 121:5015-5024.
79. Sun Y., Campisi J., Higano C., Beer T.M., Porter P., Coleman I., et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nature Medicine 2012, 18:1359-1368.
80. Van Ginderachter J.A., Movahedi K., Hassanzadeh Ghassabeh G., Meerschaut S., Beschin A., Raes G., et al. Classical and alternative activation of mononuclear phagocytes: Picking the best of both worlds for tumor promotion. Immunobiology 2006, 211:487-501.
81. Wilson W. The regulation of constitutive NF-κB activity by glycogen synthase kinase-3 in pancreatic cancer. ProQuest 2009, UNC-Chapel Hill Dissertation.
82. Wynn T.A., Chawla A., Pollard J.W. Macrophage biology in development, homeostasis and disease. Nature 2013, 496:445-455.
83. Xia Y., Padre R.C., De Mendoza T.H., Bottero V., Tergaonkar V.B., Verma I.M. Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:2629-2634.
84. Xia Y., Yeddula N., Leblanc M., Ke E., Zhang Y., Oldfield E., et al. Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model. Nature Cell Biology 2012, 14:257-265.
85. Yang X.D., Tajkhorshid E., Chen L.F. Functional interplay between acetylation and methylation of the RelA subunit of NF-kappaB. Molecular and Cellular Biology 2010, 30:2170-2180.
86. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: A leading role for STAT3. Nature Reviews. Cancer 2009, 9:798-809.
87. Zaynagetdinov R., Stathopoulos G.T., Sherrill T.P., Cheng D.S., McLoed A.G., Ausborn J.A., et al. Epithelial nuclear factor-kappaB signaling promotes lung carcinogenesis via recruitment of regulatory T lymphocytes. Oncogene 2012, 31:3164-3176.
88. Zhang L., Conejo-Garcia J.R., Katsaros D., Gimotty P.A., Massobrio M., Regnani G., et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. The New England Journal of Medicine 2003, 348:203-213.
89. Zhang W., Tan W., Wu X., Poustovoitov M., Strasner A., Li W., et al. A NIK-IKKalpha module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27/Kip1. Cancer Cell 2013, 23:647-659.